PMV PHARMACEUTICALS INC (PMVP) Forecast, Price Target & Analyst Ratings

NASDAQ:PMVP • US69353Y1038

Current stock price

1.38 USD
+0.01 (+0.73%)
At close:
1.4 USD
+0.02 (+1.45%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PMV PHARMACEUTICALS INC (PMVP).

Forecast Snapshot

Consensus Price Target

Price Target
$7.75
+ 461.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 8, 2026
Period
Q1 / 2026
EPS Estimate
-$0.42
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.75
Upside
+ 461.74%
From current price of $1.38 to mean target of $7.75, Based on 12 analyst forecasts
Low
$4.04
Median
$6.12
High
$16.80

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for PMVP. The average price target is 7.75 USD. This implies a price increase of 461.74% is expected in the next year compared to the current price of 1.38.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PMVP Current Analyst RatingPMVP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

PMVP Historical Analyst RatingsPMVP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
PMVP was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PMVP.
In the previous month the buy percentage consensus was at a similar level.
PMVP was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-03-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-13Craig-HallumInitiate Buy
2024-04-12JefferiesInitiate Buy
2024-03-07HC Wainwright & Co.Reiterate Buy -> Buy
2023-12-27Ladenburg ThalmannInitiate Buy
2023-10-16HC Wainwright & Co.Maintains Buy -> Buy
2023-08-11HC Wainwright & Co.Maintains Buy -> Buy
2023-05-17HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-11OppenheimerReiterate Outperform -> Outperform
2023-03-20HC Wainwright & Co.Maintains Buy
2023-03-02OppenheimerMaintains Outperform
2022-11-17HC Wainwright & Co.Maintains Buy
2022-06-09OppenheimerMaintains Outperform
2022-05-24Goldman SachsMaintains Buy
2022-03-02OppenheimerUpgrade Perform -> Outperform
2021-09-22Goldman SachsUpgrade Neutral -> Buy
2021-08-19OppenheimerInitiate Perform
2021-08-02GuggenheimInitiate Buy
2021-07-29HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 8, 2026
Period
Q1 / 2026
EPS Estimate
-$0.42
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-23.00%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-1.86%
EPS (3 Months)
-23.00%

Next Earnings Summary

PMVP is expected to report earnings on 5/8/2026. The consensus EPS estimate for the next earnings is -0.42 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PMVP revenue by date.PMVP revenue by date.
N/AN/AN/A
720.11%		N/A
129.62%		N/A
178.37%		N/A
49.40%		N/A
17.75%		N/A
15.66%
EBITDA
YoY % growth
PMVP ebitda by date.PMVP ebitda by date.
-18.55M-26.25M
-41.51%		-34.62M
-31.89%		-57.98M
-67.48%		-76.72M
-32.32%		-78.875M
-2.81%		-84.304M
-6.88%		-86.073M
-2.10%		N/A
-43.45%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
PMVP ebit by date.PMVP ebit by date.
-18.89M-26.64M
-41.03%		-34.94M
-31.16%		-58.29M
-66.83%		-77.04M
-32.17%		-80.132M
-4.01%		-85.448M
-6.63%		-86.206M
-0.89%		N/A
-6.78%		N/A
1.58%		N/A
16.31%		N/A
0.56%		N/A
62.95%		N/A
228.74%		N/A
84.73%		N/A
47.51%
Operating Margin
PMVP operating margin by date.PMVP operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
PMVP eps by date.PMVP eps by date.
N/AN/AN/A-1.28
39.01%		-1.62
-26.56%		-1.45
10.49%		-1.14
21.38%		-1.49
-30.70%		N/A
-7.48%		N/A
26.11%		N/A
16.38%		N/A
40.21%		N/A
129.31%		N/A
347.06%		N/A
42.11%		N/A
31.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.42
-23.00%		-0.44
-7.80%		-0.39
2.25%		-0.35
-4.00%		-0.37
12.20%		-0.30
33.08%		-0.30
24.35%		-0.27
23.56%
Revenue
Q2Q % growth		1.219M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-22.823M
-5.84%		-22.823M
0.25%		-23.205M
-3.03%		-23.205M
-20.60%		-23.078M
-1.12%		-23.103M
-1.23%		-23.001M
0.88%		-21.418M
7.70%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PMVP Yearly Revenue VS EstimatesPMVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
PMVP Yearly EPS VS EstimatesPMVP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.14%
EPS Next 5 Year
16.18%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PMV PHARMACEUTICALS INC / PMVP Forecast FAQ

What is the price target for PMVP stock?

12 analysts have analysed PMVP and the average price target is 7.75 USD. This implies a price increase of 461.74% is expected in the next year compared to the current price of 1.38.

Can you provide the upcoming earnings date for PMV PHARMACEUTICALS INC?

PMV PHARMACEUTICALS INC (PMVP) will report earnings on 2026-05-08.

Can you provide the consensus estimates for PMV PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of PMV PHARMACEUTICALS INC (PMVP) is -0.42 USD and the consensus revenue estimate is 0 USD.

How many analysts cover PMV PHARMACEUTICALS INC (PMVP) stock?

The number of analysts covering PMV PHARMACEUTICALS INC (PMVP) is 12.